For the first five months of this year, revenues from sales decreased by 13% compared to the same period of 2015, including 3% decrease of domestic sales and a 19% decrease of export sales, which is due to the lower number of workdays in the month of May.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that for April 2016 Sopharma AD realized a decrease of sales revenues of 19% compared to the same month of last year, including retention of the level of domestic sales and 29% decrease of export sales.

Sopharma AD notifies that the Board of Directors of Sopharma AD authorized the executive director of the company to enter into a contract for the sale of the shareholding of Sopharma AD in the capital of Ivanchich and Sons, Serbia. The transaction was concluded on May 9th, 2016 in Belgrade, Serbia. The parameters of the transaction are subject to confidentiality clauses in the interest of the all parties. Sopharma AD will continue its activities on the Serbian market through its daughter company Sopharma Trading AD.